Abiraterone in low-volume metastatic hormone-sensitive prostate cancer

Actas Urol Esp (Engl Ed). 2023 Jul-Aug;47(6):390-392. doi: 10.1016/j.acuroe.2023.05.004. Epub 2023 May 18.

[Article in English, Spanish]

Authors

R García-Fumero¹, M Piñero-González²

Affiliations

¹ Servicio de Farmacia, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Las Palmas, Spain. Electronic address: [email protected].
² Servicio de Farmacia, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Las Palmas, Spain.

PMID: 37209784
DOI: 10.1016/j.acuroe.2023.05.004

No abstract available

Publication types

Letter
Comment

MeSH terms

Androstenes / therapeutic use
Hormones
Humans
Male
Prostatic Neoplasms* / drug therapy
Prostatic Neoplasms* / pathology

Substances

abiraterone
Androstenes
Hormones